Transcriptomics

Dataset Information

0

High-throughput 3D screening reveals differences in drug sensitivities between culture models of JIMT1 breast cancer cells.


ABSTRACT: The traditional method for studying cancer in vitro is to grow immortalized cancer cells in two-dimensional (2D) monolayers on plastic. However, many cellular features are impaired in these unnatural conditions and big alterations in gene expression in comparison to tumors have been reported. Three-dimensional (3D) cell culture models have become increasingly popular and are suggested to be better models than 2D monolayers due to improved cell-to-cell contacts and structures that resemble in vivo architecture. The aim of this study was to develop a simple high-throughput 3D drug screening method and to compare drug responses in JIMT1 breast cancer cells when grown in 2D, in polyHEMA coated anchorage independent 3D models and in Matrigel on-top 3D cell culture models. We screened 102 compounds with multiple concentrations and biological replicates for their effects on cell proliferation. The cells were either treated immediately upon plating or they were allowed to grow in 3D for four days prior to the drug treatment. Big variations in drug responses were observed between the models indicating that comparisons of culture model influenced drug sensitivities cannot be made based on effects of a single drug. However, we show with the 63 most prominent drugs that, in general, JIMT1 cells grown on Matrigel were significantly more sensitive to drugs than cells grown in 2D cultures, while responses of cells grown in polyHEMA resembled those of 2D. Furthermore, comparison of gene expression profiles of the cell culture models to xenograft tumors indicated that cells cultured in Matrigel and as xenografts most closely resembled each other. In this study we also suggest that 3D cultures can provide a platform for systematic experimentation of larger compound collections in a high-throughput mode and be used as alternatives for traditional 2D screens towards better comparability to in vivo state.

ORGANISM(S): Homo sapiens

PROVIDER: GSE42529 | GEO | 2013/10/30

SECONDARY ACCESSION(S): PRJNA182210

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2013-10-30 | E-GEOD-42529 | biostudies-arrayexpress
2013-10-30 | GSE47583 | GEO
2013-10-30 | E-GEOD-47583 | biostudies-arrayexpress
2016-11-24 | GSE71259 | GEO
2020-09-26 | GSE158597 | GEO
2015-12-10 | E-GEOD-75863 | biostudies-arrayexpress
2010-08-25 | E-GEOD-23773 | biostudies-arrayexpress
2010-08-25 | GSE23773 | GEO
2019-12-20 | GSE138676 | GEO
2015-12-10 | GSE75863 | GEO